AstraZeneca PLC

Pharmaceuticals
United Kingdom
Earnings Per Share Growth (%)127.55%
Cost of Goods Sold (US$ Millions)$4,646
Current Liabilities (US$ Millions)$14,869
Total Assets (US$ Millions)$16,007
Long Term Debt$14,137
Return on Equity14.39%
Revenue (US$ Millions)$24,708
Total Company Assets$60,124
Revenue Growth (%)-5.32%
Net Income (US$ Millions)$2,825
Earnings Per Share (US$)$127.55
Total Equity (US$ Millions)$18,490
Profit Margin (%)11.43%
Debt To Equity Ratio (%)0.76%
Inventory Turnover$2,143